Literature DB >> 19115891

Intermittent subcutaneous opioids for the management of cancer pain.

Henrique A Parsons1, Abdul Shukkoor, Hue Quan, Marvin O Delgado-Guay, J Lynn Palmer, Robin Fainsinger, Eduardo Bruera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19115891      PMCID： PMC2982713          DOI： 10.1089/jpm.2008.0155

Source DB:  PubMed          Journal:  J Palliat Med        ISSN： 1557-7740            Impact factor:   2.947


× No keyword cloud information.
  25 in total

1.  Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration.

Authors:  Rachel C Koshy; Renju Kuriakose; Paul Sebastian; Cherian Koshy
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

Review 2.  The epidemiology of cancer pain.

Authors:  Leonidas C Goudas; Rina Bloch; Maria Gialeli-Goudas; Joseph Lau; Daniel B Carr
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

Review 3.  The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991--2006).

Authors:  Cheryl Nekolaichuk; Sharon Watanabe; Crystal Beaumont
Journal:  Palliat Med       Date:  2008-03       Impact factor: 4.762

4.  Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study.

Authors:  P G Lawlor; B Gagnon; I L Mancini; J L Pereira; J Hanson; M E Suarez-Almazor; E D Bruera
Journal:  Arch Intern Med       Date:  2000-03-27

5.  Symptom priority and course of symptomatology in specialized palliative care.

Authors:  Annette S Strömgren; Per Sjogren; Dorthe Goldschmidt; Morten Aagaard Petersen; Lise Pedersen; Mogens Groenvold
Journal:  J Pain Symptom Manage       Date:  2006-03       Impact factor: 3.612

6.  The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain.

Authors:  B Gagnon; M Bielech; S Watanabe; P Walker; J Hanson; E Bruera
Journal:  Support Care Cancer       Date:  1999-07       Impact factor: 3.603

7.  Intermittent subcutaneous injections of pain medication: effectiveness, manageability, and satisfaction.

Authors:  M Letizia; J Shenk; T D Jones
Journal:  Am J Hosp Palliat Care       Date:  1999 Jul-Aug       Impact factor: 2.500

8.  Validation of the Edmonton Symptom Assessment Scale.

Authors:  V T Chang; S S Hwang; M Feuerman
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

9.  A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.

Authors:  Sharon Watanabe; Jose Pereira; Yoko Tarumi; John Hanson; Eduardo Bruera
Journal:  J Palliat Med       Date:  2008-05       Impact factor: 2.947

10.  Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: a prospective study.

Authors:  E Bruera; T MacEachern; K Macmillan; M J Miller; J Hanson
Journal:  J Pain Symptom Manage       Date:  1993-05       Impact factor: 3.612
View more
  5 in total

1.  A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic.

Authors:  Matthew P Lazio; Heather H Costello; D Mark Courtney; Zoran Martinovich; Randall Myers; Amy Zosel; Paula Tanabe
Journal:  Clin J Pain       Date:  2010 Mar-Apr       Impact factor: 3.442

2.  Methadone initiation and rotation in the outpatient setting for patients with cancer pain.

Authors:  Henrique A Parsons; Maxine de la Cruz; Badi El Osta; Zhijun Li; Bianca Calderon; J Lynn Palmer; Eduardo Bruera
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

3.  The role of subcutaneous ketorolac for pain management.

Authors:  Mary E Vacha; Wennie Huang; Jennifer Mando-Vandrick
Journal:  Hosp Pharm       Date:  2015-02

4.  Evaluation of the optimal positioning of subcutaneous butterfly when administering injectable opioids in cancer patients.

Authors:  Nicoleta Mitrea; Daniela Mosoiu; Julie Vosit-Steller; Liliana Rogozea
Journal:  Clujul Med       Date:  2016-10-20

5.  Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center.

Authors:  Per Fürst; Staffan Lundström; Pål Klepstad; Peter Strang
Journal:  BMC Palliat Care       Date:  2020-11-10       Impact factor: 3.234
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.